Form HLTH5345 Special Authority Request - Targeted Dmards for Rheumatoid Arthritis: Initial / Switch - British Columbia, Canada

Form HLTH5345 is used in British Columbia, Canada to request special authority for targeted disease-modifying anti-rheumatic drugs (DMARDs) for the treatment of Rheumatoid Arthritis. This form is used for both initial requests and switch requests. It allows patients to access these medications under specific conditions and criteria set by the health authority.

The Form HLTH5345 Special Authority Request for Targeted DMARDs for Rheumatoid Arthritis in British Columbia, Canada is usually filed by the prescribing physician or healthcare provider.

FAQ

Q: What is HLTH5345 Special Authority Request?
A: HLTH5345 Special Authority Request is a form used in British Columbia, Canada to request targeted DMARDs for rheumatoid arthritis.

Q: What are targeted DMARDs?
A: Targeted DMARDs are a type of medication used to treat rheumatoid arthritis.

Q: Who can use HLTH5345 Special Authority Request?
A: HLTH5345 Special Authority Request can be used by residents of British Columbia, Canada with rheumatoid arthritis who need targeted DMARDs.

Q: Can HLTH5345 Special Authority Request be used for initial or switch treatment?
A: Yes, HLTH5345 Special Authority Request can be used for both initial and switch treatment of rheumatoid arthritis with targeted DMARDs.

Q: Is there any specific eligibility criteria for HLTH5345 Special Authority Request?
A: Yes, there are specific eligibility criteria for HLTH5345 Special Authority Request, which are outlined in the form itself.

Q: Is there a fee for submitting HLTH5345 Special Authority Request?
A: No, there is no fee for submitting HLTH5345 Special Authority Request.